Bayhill Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
321 Dedalera Dr, Portola Valley, Califor...Phone Number
(650) 320-2800Website
www.bayhilltx.comRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Bayhill Therapeutics
Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics for autoimmune diseases. The company uses its therapeutic BHT-DNA platform to develop a pipeline of treatment candidates for autoimmune diseases. Its products in clinical pipeline include BHT-3021, which is in Phase I/II clinical trial for reducing or eliminating the immune systems attack on the pancreas; BHT-3009, which completed its Phase II trial for the treatment of multiple sclerosis; and BHT-3034, which is in preclinical studies for the treatment of myasthenia gravis. The company was formerly known as Tolerion, Inc. and changed its name to Bayhill Therapeutics, Inc. in November 2002. Bayhill Therapeutics, Inc. was founded in 2000 and is headquartered in Palo Alto, California.Explore more
Bayhill Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bayhill Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Bayhill Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Bayhill Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Bayhill Therapeutics has new funding data
Product Launch: Get notified when Bayhill Therapeutics launches new products
Click to see if Bayhill Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Bayhill Therapeutics
Earning: See what the market has to say on Bayhill Therapeutics recently announced quarterly report
Check out if Bayhill Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Bayhill Therapeutics
Find 2 more new buyers
Compare Similar Companies to Bayhill Therapeutics
Compare insights from companies similar to Bayhill Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2000
JH
Jun HayashiPresident of Precision Antibody, Vice President of A & G Pharmaceutical Inc
Company Profile Activity
Activity Insights
Bayhill Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bayhill Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bayhill Therapeutics.
Bayhill Therapeutics Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bayhill Therapeutics
Sign Up For FreeTo access detailed company insights
Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics for autoimmune diseases. The company uses its therapeutic BHT-DNA platform to develop a pipeline of treatment candidates for autoimmune diseases. Its products in clinical pipeline include BHT-3021, which is in Phase I/II cl... Read More
